Scopolamine-induced memory impairment in mice: Soursop leaf extract and fractions protect the hippocampus and prefrontal cortex

Document Type : Original Article

Authors

1 Neuropharmacology Unit, Department of Pharmacology and Therapeutics, Faculty of Basic Medical Sciences, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria

2 Department of Pharmacology & Therapeutics, Faculty of Basic Clinical Sciences, Bowen University, Iwo, Nigeria

3 Department of Pharmacology & Therapeutics, Faculty of Medicine and Pharmacy, Kampala International University in Tanzania, Dar Es Salaam, United Republic of Tanzania

4 School of Nursing, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana

10.22038/ijbms.2024.80289.17379

Abstract

Objective(s): Annona muricata” (soursop) is a medicinal plant with diverse ornamental, consumptive, and pharmacological importance. This study was designed for its anti-amnesic potential in mice. 
Materials and Methods: The crude extract was fractionated with n-hexane, ethyl acetate, and aqueous methanol. The crude and fractions were tested in vitro for the anti-oxidant radical scavenging activity (DPPH), total flavonoid and phenolic content, and their acetylcholinesterase inhibitory activity. Thin-layer chromatography was used to determine the phytochemicals contained in the fractions and their purity. Neurobehavioral models like the Open Field Test, Novel Object Recognition Test, Y-Maze, and Morris Water Maze were used to evaluate the action of AMME (Annona muricata methanol extract) and AMAMF (Annona muricata aqueous methanol fraction). 
Results: The AMME and AMAMF significantly reduced the serum levels of myeloperoxidase and arginine (P<0.05). They also modulate the hippocampal and prefrontal acetylcholinesterase and glutamic acid decarboxylase activities (P<0.05). The 25 mg/kg AMAMF significantly affected short-term memory (P<0.05). The AMAMF and AMME significantly enhanced the prefrontal and hippocampal tissue levels of glutathione and superoxide dismutase. During the in vitro AchE assay on all fractions, the AMME and AMAMF consistently showed the greatest percentage of inhibitory activity. They inhibited 50% of the AchE enzymes with the lowest concentration. 
Conclusion: The study showed the neuroprotective effects of AMME and AMAMF in memory impairment models. The extracts showed potent AChE inhibition and positive effects on memory and anti-oxidant enzyme levels. 

Keywords

Main Subjects


1. Bhushan I, Kour M, Kour G, Gupta S, Sharma S, Yadav A. Alzheimer’s disease: Causes & treatment–A review. Ann Biotechnol 2018;1:1002-1009. 
2. Oyeleke MB, Owoyele BV. Saponins and flavonoids from Bacopa floribunda plant extract exhibit antioxidant and anti- inflammatory effects on amyloid beta 1-42-induced Alzheimer’s disease in BALB/c mice. J Ethnopharmacol 2022; 288:114997. 
3. Nazir N, Zahoor M, Nisar M, Karim N, Latif A, Ahmad S, et al. Evaluation of neuroprotective and anti-amnesic effects of Elaeagnus umbellata thunb. on scopolamine-induced memory impairment in mice. BMC Complement Med Ther 2020; 20:1-17. 
4. Goldstein G. Delirium, dementia and amnestic and other cognitive disorders (neurocognitive disorders). Adult Psychopathol Diagn 2011;149. 
5. Tönnies E, Trushina E. Oxidative stress, synaptic dysfunction, and Alzheimer’s disease. J Alzheimers Dis 2017;57:1105-1121. 
6. Meneses A. Neurotransmitters and memory: Cholinergic, glutamatergic, gabaergic, dopaminergic, serotonergic signaling and memory. In: Identification of Neural Markers Accompanying Memory. Elsevier 2014. P. 5-45. 
7. Daulatzai MA. Early stages of pathogenesis in memory impairment during normal senescence and Alzheimer’s disease. J Alzheimers Dis 2010; 20:355-367. 
8. Cheng YJ, Lin CH, Lane HY. Involvement of cholinergic adrenergic and glutamatergic network modulation with cognitive dysfunction in Alzheimer’s disease. Int J Mol Sci 2021; 22:2283-2297. 
9. Gavamukulya Y, Wamunyokoli F, El-Shemy HA. Annona muricata: Is the natural therapy to most disease conditions including cancer growing in our backyard? A systematic review of its research history and future prospects. Asian Pac J Trop Med 2017; 10: 835–848. 
10. Mutakin M, Fauziati R, Fadhilah FN, Zuhrotun A, Amalia R, Hadisaputri YE. Pharmacological activities of soursop (Annona muricata Lin.). Molecules 2022; 27:1201-1217. 
11. Coria-Téllez AV, Montalvo-Gónzalez E, Yahia EM, Obledo- Vázquez EN. Annona muricata: A comprehensive review on its traditional medicinal uses, phytochemicals, pharmacological activities, mechanisms of action and toxicity. Arab J Chem 2018; 11:662-691. 
12. Singh D, Hembrom S, Raj A. Neuroprotective effect of flavonoids: A systematic review. J Pharmacogn Phytochem 2019; 8:699-707. 
13. Zemdegs J, Quesseveur G, Jarriault D, Pénicaud L, Fioramonti X, Guiard BP. High-fat diet-induced metabolic disorders impair 5-HT function and anxiety-like behavior in mice. Br J Pharmacol 2016; 173:2095-2110. 
14. Afolabi O, Alabi B, Omobowale T, Oluranti O, Iwalewa O. Cysteamine mitigates torsion/detorsion‐induced reperfusion injury via inhibition of apoptosis, oxidative stress and inflammatory responses in experimental rat model. Andrologia 2022; 54:e14243. 
15. Oladele JO, Oyeleke OM, Olowookere BD, Babatope OD, Olaniyan MD, Akindolie BO, Oladele OT. Bitter leaf (Vernonia amygdalina) modulates nitrobenzene-induced renal damage in rats via suppression of oxido-inflammatory activities. EABR 2021; 22:317-324. 
16. Ajayi AM, Ben-Azu B, Onasanwo SA, Adeoluwa O, Eduviere A, Ademowo OG. Flavonoid-rich fraction of ocimum gratissimum attenuates lipopolysaccharide-induced sickness behavior, inflammatory and oxidative stress in mice. Drug Res (Stuttg) 2019; 69:151–158. 
17. Postua PA, Sadiki FZ, Idrissi ME, Cioanca O, Trifan A, Hritcu L. Pinus halepensis essential oil attenuates the toxic alzheimer’s amyloid beta (1-42)-induced memory impairment and oxidative stress in the rat hippocampus. Biomed Pharmacother 2019; 112:108673. 
18. Gella A, Durany N. Oxidative stress in alzheimer’s disease. Cell Adh Migr 2009; 3:88–93. 
19. Zhao Y, Zhao B. Oxidative stress and the pathogenesis of alzheimer’s disease. Oxid Med Cell Longev 2013; 2013:316523. 
20. McHardy SF, Wang HYL, McCowen SV, Valdez MC. Recent advances in acetylcholinesterase inhibitors and reactivators: An update on the patent literature (2012-2015). Expert Opin Ther Pat 2017; 27:455-76. 
21. Szpręgiel I, Wrońska D, Kmiecik M, Pałka S, Kania BF. Glutamic acid decarboxylase concentration changes in response to stress and altered availability of glutamic acid in rabbit (Oryctolagus cuniculus) brain limbic structures. Animals 2021; 11:455. 
22. Newman LA, Gold PE. Attenuation in rats of impairments of memory by scopolamine, a muscarinic receptor antagonist, by mecamylamine, a nicotinic receptor antagonist. Psychopharmacology (Berl) 2016; 233:925-932. 
23. Lu C, Shi Z, Dong L, Lv J, Xu P, Li Y, et al. Exploring the effect of ginsenoside Rh1 in a sleep deprivation-induced mouse memory impairment model. Phytother Res 2017; 31:763-770. 
24. Cai P, Fang SQ, Yang XL, Wu JJ, Liu QH, Hong H, et al. Rational design and multibiological profiling of novel donepezil– trolox hybrids against alzheimer’s disease with cholinergic anti-oxidant neuroprotective and cognition-enhancing properties. ACS Chem Neurosci 2017; 8:2496-2511. 
25. Chesworth R, Gamage R, Ullah F, Sonego S, Millington C, Fernandez A, et al. Spatial memory and microglia activation in a mouse model of chronic neuroinflammation and the anti- inflammatory effects of apigenin. Front Neurosci 2021; 15:699329. 
26. Quilez AM, Montserrat-de la Paz S, De la Puerta R, Fernández-Arche MA, García-Giménez MD. Validation of ethnomedicinal use as anti-inflammatory of a decoction from Annona muricata leaves. Afr J Tradit Complement Altern Med 2015; 12:14-20. 
27. Al Omairi NE, Al-Brakati AY, Kassab RB, Lokman MS, Elmahallawy EK, Amin HK, et al. Soursop fruit extract mitigates scopolamine-induced amnesia and oxidative stress via activating cholinergic and Nrf2/HO-1 pathways. Metab Brain Dis 2019; 34:853-864. 
28. Bourgognon JM, Cavanagh J. The role of cytokines in modulating learning and memory and brain plasticity. BNA 2020; 4:2398212820979802. 
29. Yoon WB, Cho HJ, Kim JE, Park JW, Kang MJ, Bae SJ, et al. Comparison of scopolamine-induced cognitive impairment responses in three different ICR stocks. Lab Anim Res 2018; 34:317-328. 
30. Etibor TA, Ajibola MI, Buhari MO, Safiriyu AA, Akinola OB, Caxton-Martins EA. Datura metel administration distorts medial prefrontal cortex histology of Wistar rats. World J Neurosci 2015; 5:282-291.